| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.53B | -1.5% |
| R&D Expense | $277.9M | -9.6% |
| SG&A Expense | $431.9M | -0.8% |
| Operating Income | -$263.0M | +74.2% |
| Pre-tax Income | -$235.5M | +76.3% |
| Income Tax | -$35.2M | -563.8% |
| Net Income | -$200.3M | +80.0% |
| EPS (Basic) | -$1.14 | +80.6% |
| EPS (Diluted) | -$1.14 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $781.1M | -39.8% |
| Accounts Receivable | $192.8M | -10.0% |
| Inventory | $38.2M | +0.2% |
| Current Assets | $1.12B | -32.7% |
| Total Assets | $2.86B | -18.7% |
| Current Liabilities | $404.7M | -57.0% |
| Total Liabilities | $1.47B | -27.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $294.4M | +0.2% |
| Capital Expenditures | $8.9M | -17.6% |
| Investing Cash Flow | -$266.0M | -114.4% |
| Financing Cash Flow | -$551.7M | -6736.8% |
| Free Cash Flow | $285.5M | +0.9% |
| +80.6% |
| Stockholders' Equity |
| $1.39B |
| -7.1% |